NLS Pharmaceutics Ltd (NASDAQ:NLSP) has a beta value of -0.40 and has seen 15.01 million shares traded in the last trading session. The company, currently valued at $5.68M, closed the last trade at $2.30 per share which meant it gained $0.24 on the day or 11.65% during that session. The NLSP stock price is -873.48% off its 52-week high price of $22.39 and 24.78% above the 52-week low of $1.73. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.28 million shares traded. The 3-month trading volume is 737.14K shares.
The consensus among analysts is that NLS Pharmaceutics Ltd (NLSP) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Sporting 11.65% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NLSP stock price touched $2.30 or saw a rise of 7.63%. Year-to-date, NLS Pharmaceutics Ltd shares have moved 9.00%, while the 5-day performance has seen it change 9.00%. Over the past 30 days, the shares of NLS Pharmaceutics Ltd (NASDAQ:NLSP) have changed 5.50%. Short interest in the company has seen 0.13 million shares shorted with days to cover at 0.33.
NLS Pharmaceutics Ltd (NLSP) estimates and forecasts
The company’s shares have lost -71.55% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.15% over the past 5 years.
NLSP Dividends
NLS Pharmaceutics Ltd is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
The top two institutional holders are BVF INC/IL with over 5.75 million shares worth more than $1.25 million. As of 2024-06-30, BVF INC/IL held 15.0543% of shares outstanding.
The other major institutional holder is ARMISTICE CAPITAL, LLC, with the holding of over 2.31 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.5 million and represent 6.0535% of shares outstanding.
